895582-60-2

Upstream product

• 501426-61-5 1-(2,4-dichlorophenyl)-5-(4-hydroxyphenyl)-4-methyl-1H-pyrazole-3-carboxylic acid 
• 895582-58-8 5-[4-(tert-butyldimethyl-silanyloxy)phenyl]-1-(2,4-dichloro-phenyl)-4-methyl-1H-pyrazole-3-carboxylic acid methyl ester 
• 895582-57-7 1-(2,4-dichlorophenyl)-5-(4-hydroxyphenyl)-4-methyl-1H-pyrazole-3-carboxylic acid methyl ester 
• 895582-59-9 4-bromomethyl-5-[4-(tert-butyldimethyl-silanyloxy)phenyl]-1-(2,4-dichloro-phenyl)-1H-pyrazole-3-carboxylic acid methyl ester 

Downstream Products

• 895582-67-9 1-(2,4-dichlorophenyl)-4-hydroxymethyl-5-(4-hydroxyphenyl)-1H-pyrazole-3-carboxylic acid cyclohexylamide 
• 895582-66-8 1-(2,4-dichloro-phenyl)-4-hydroxymethyl-5-(4-(3,3,3-trifluoropropane-1-sulphonyloxy)phenyl)-1H-pyrazole-3-carboxylic acid 
• 895582-65-7 1-(2,4-dichloro-phenyl)-4-hydroxymethyl-5-(4-(3,3,3-trifluoropropane-1-sulphonyloxy)phenyl)-1H-pyrazole-3-carboxylic acid methyl ester 

Relevant academic research and scientific papers

THERAPEUTIC AGENTS

The present invention relates to a 1,5-diphenylpyrazole compound and its use in the treatment of obesity, psychiatric and neurological disorders, to methods for the its therapeutic use and to pharmaceutical compositions containing them.

THERAPEUTIC AGENTS

The present invention relates to a 1,5-diphenylpyrazole compound and its use in the treatment of obesity, psychiatric and neurological disorders, to methods for the its therapeutic use and to pharmaceutical compositions containing them.

THERAPEUTIC AGENTS

The present invention relates to 1,5-diphenylpyrazole compounds of formula I (A chemical formula should be inserted here - please see paper copy enclosed herewith) and processes for preparing such compounds, their use in the treatment of obesity, psychiatric and neurological disorders, to methods for their therapeutic use and to pharmaceutical compositions containing them.